Furthermore, since periodontitis may be a risk factor for the development of age-related neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases (see Paragraph 2), strategies aimed at modulating NRF2/KEAP1 signaling during periodontitis may protect against the onset/progression of these neurodegenerative diseases. Here, KEAP1 is linked to periodontitis.